Celldex Therapeutics Inc (CLDX)
Healthcare
Biotechnology
37.70 $
-1.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Celldex Therapeutics Inc (CLDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -211 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -102 | -99 | -113 | -100 | -75 | -46 | -40 | -61 | -104 | -107 | -158 | -211 | |
| 3.4 | 4.0 | 4.1 | 5.3 | 3.8 | 4.9 | 3.9 | 3.1 | 1.4 | 3.0 | 3.2 | -2.5 | |
| 6.9 | 13 | 15 | 12 | 8.1 | 4.6 | 3.9 | 9.0 | 16 | 24 | 34 | 36 | |
| 6.8 | 13 | 15 | 0.3 | 89 | 5.1 | 16 | 7.6 | 9.6 | – | – | – | |
| 6.1 | 11 | -6.6 | -12 | -15 | -4.3 | -0.3 | -1.1 | -3.9 | 13 | -22 | 14 | |
| 1.9 | 4.9 | 2.8 | 1.8 | 0.8 | 0.7 | 1.6 | 1.2 | 1.8 | 1.8 | 1.9 | 2.7 | |
| -41 | -50 | 69 | 46 | 30 | 17 | -98 | -216 | 90 | -106 | -290 | 209 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 1.2 | 193 | 14 | 51 | 29 | 16 | 171 | 272 | – | – | – | – | |
| – | – | – | – | – | – | – | 0.0 | 0.0 | – | – | – | |
| 1.2 | 193 | 14 | 51 | 29 | 16 | 171 | 272 | 4.1 | 218 | 441 | 2.4 | |
| -141 | 44 | -30 | -2.2 | -16 | -13 | 33 | -4.7 | -9.7 | 5.4 | -6.5 | 0.5 | |
| -103 | -104 | -116 | -102 | -76 | -47 | -42 | -62 | -106 | -109 | -160 | -214 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.